|
Market Closed -
Nasdaq
04:00:00 26/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 57.43 USD | -0.16% |
|
+0.98% | +92.65% |
| 08-04 | TG Therapeutics, Inc. Raises Earnings Guidance for the Full Year 2026 | CI |
| 08-03 | TG Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 8.15B 7.15B 6.75B 6.15B 11.52B 781B 11.6B 80.79B 31.29B 399B 30.59B 29.92B 1,282B | P/E 2026 * |
60.7x | P/E 2027 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 8.32B 7.3B 6.89B 6.28B 11.76B 797B 11.84B 82.47B 31.94B 407B 31.22B 30.55B 1,309B | EV / Sales 2026 * |
8.66x | EV / Sales 2027 * | 5.92x |
| Free-Float |
88.56% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TGTX | Delayed | |
CBOE
| TGTX | Real-time | |
London S.E.
| 0VGI | Delayed | |
Tradegate
| NKB2 | Real-time | |
Deutsche Boerse AG
| NKB2 | Delayed | |
Börse Stuttgart
| NKB2 | Delayed | |
Boerse Muenchen
| NKB2 | Real-time | |
Berne S.E.
| NKB2 | End-of-day quote | |
Borsa Italiana
| 1TGTX | End-of-day quote |
Last Transcript: TG Therapeutics, Inc.
| 1 day | -0.16% | ||
| 1 week | +0.98% | ||
| Current month | +5.76% | ||
| 1 month | +3.63% | ||
| 3 months | +7.09% | ||
| 6 months | +80.48% | ||
| Current year | +92.65% |
| 1 week | 54.78 | 58.92 | |
| 1 month | 52.11 | 58.92 | |
| Current year | 26.76 | 59.3 | |
| 1 year | 26.76 | 59.3 | |
| 3 years | 6.46 | 59.3 | |
| 5 years | 3.48 | 59.3 | |
| 10 years | 3.32 | 59.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Weiss
CEO | Chief Executive Officer | 60 | 29/12/2011 |
Sean Power
DFI | Director of Finance/CFO | 44 | 29/12/2011 |
Jenna A. Bosco
IRC | Investor Relations Contact | - | 01/12/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Weiss
CHM | Chairman | 60 | 29/12/2011 |
Laurence Charney
BRD | Director/Board Member | 79 | 01/03/2012 |
Yann Echelard
BRD | Director/Board Member | 62 | 09/11/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/9/26 | Sell | Director | -5,000 | 0.0033% | ||
| 7/8/26 | Don | Director | -950 | 0.0006% | ||
| 28/1/26 | Don | Director | 43,197 | 0.0272% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.16% | +0.98% | +65.79% | +539.53% | 8.15B | ||
| +0.13% | +2.65% | +65.61% | +114.28% | 1,055B | ||
| +0.20% | +0.46% | +52.60% | +69.24% | 654B | ||
| -0.29% | +0.14% | +20.96% | +70.93% | 467B | ||
| -0.85% | +0.98% | +41.29% | +44.38% | 348B | ||
| +0.71% | +4.08% | +22.24% | +29.51% | 275B | ||
| +1.23% | +0.42% | +14.57% | +12.13% | 258B | ||
| +2.11% | +7.51% | +52.89% | +55.37% | 224B | ||
| +0.83% | +0.55% | +35.99% | +101.70% | 187B | ||
| 0.00% | -10.14% | -29.94% | -60.30% | 171B | ||
| Average | +0.31% | +0.76% | +34.20% | +97.68% | 364.65B | |
| Weighted average by Cap. | +0.02% | +1.32% | +41.59% | +68.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 960M 843M 796M 725M 1.36B 92.03B 1.37B 9.52B 3.69B 47.01B 3.6B 3.53B 151B | 1.32B 1.16B 1.09B 995M 1.86B 126B 1.88B 13.07B 5.06B 64.54B 4.95B 4.84B 207B |
| Net income | 157M 138M 130M 119M 223M 15.09B 224M 1.56B 605M 7.71B 591M 578M 24.77B | 450M 395M 373M 340M 636M 43.14B 641M 4.46B 1.73B 22.04B 1.69B 1.65B 70.84B |
| Net Debt | 169M 148M 140M 128M 239M 16.2B 241M 1.68B 649M 8.28B 635M 621M 26.6B | -348M -305M -288M -263M -492M -33.35B -496M -3.45B -1.34B -17.04B -1.31B -1.28B -54.76B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | US$57.43 | -0.16% | 1,308,925 |
| 24/09/26 | US$57.52 | +2.71% | 1,138,354 |
| 23/09/26 | US$56.00 | -3.63% | 2,119,983 |
| 22/09/26 | US$58.11 | +1.66% | 2,084,660 |
| 21/09/26 | US$57.16 | +0.51% | 2,142,757 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TGTX Stock
Select your edition
All financial news and data tailored to specific country editions

















